Placebo to match Linaprazan glurate 50mg, Placebo to match Lansoprazole 30 mg, Linaprazan glurate, LANSOPRAZOLE
CX842A2301
Phase 3 small_molecule active
Quick answer
Placebo to match Linaprazan glurate 50mg, Placebo to match Lansoprazole 30 mg, Linaprazan glurate, LANSOPRAZOLE for Erosive esophagitis (EE) due to gastroesophageal reflux disease (GERD) is a Phase 3 program (small_molecule) at Pharma Mar S.A. with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Pharma Mar S.A.
- Indication
- Erosive esophagitis (EE) due to gastroesophageal reflux disease (GERD)
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- active